Question to the Department of Health and Social Care:
To ask His Majesty's Government what discussions they have had with experts in any of the 32 countries using Evusheld on their real time testing and trials.
The Antivirals and Therapeutics Taskforce regularly engages with international partners on the use, deployment and evaluation of therapeutics and antivirals, including Evusheld. This includes discussions with the United States Food and Drug Administration on its recent treatment guidelines which state that emerging Omicron sub-variants are likely to be resistant to Evusheld.